These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 9818660

  • 1. Concurrent generation of nitric oxide and superoxide inhibits proteoglycan synthesis in bovine articular chondrocytes: involvement of peroxynitrite.
    Oh M, Fukuda K, Asada S, Yasuda Y, Tanaka S.
    J Rheumatol; 1998 Nov; 25(11):2169-74. PubMed ID: 9818660
    [Abstract] [Full Text] [Related]

  • 2. Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis.
    Pacquelet S, Presle N, Boileau C, Dumond H, Netter P, Martel-Pelletier J, Pelletier JP, Terlain B, Jouzeau JY.
    J Rheumatol; 2002 Dec; 29(12):2602-10. PubMed ID: 12465160
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis.
    Studer RK, Georgescu HI, Miller LA, Evans CH.
    Arthritis Rheum; 1999 Feb; 42(2):248-57. PubMed ID: 10025918
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine.
    Badger AM, Cook MN, Swift BA, Newman-Tarr TM, Gowen M, Lark M.
    J Pharmacol Exp Ther; 1999 Aug; 290(2):587-93. PubMed ID: 10411566
    [Abstract] [Full Text] [Related]

  • 5. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4.
    Lubberts E, Joosten LA, van de Loo FA, van den Gersselaar LA, van den Berg WB.
    Arthritis Rheum; 2000 Jun; 43(6):1300-6. PubMed ID: 10857788
    [Abstract] [Full Text] [Related]

  • 6. Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis.
    Van de Loo FA, Arntz OJ, Van den Berg WB.
    Cytokine; 1997 Jul; 9(7):453-62. PubMed ID: 9237807
    [Abstract] [Full Text] [Related]

  • 7. Influence of oxygen tension on interleukin 1-induced peroxynitrite formation and matrix turnover in articular cartilage.
    Cernanec JM, Weinberg JB, Batinic-Haberle I, Guilak F, Fermor B.
    J Rheumatol; 2007 Feb; 34(2):401-7. PubMed ID: 17295437
    [Abstract] [Full Text] [Related]

  • 8. Differential roles of hydrogen peroxide and superoxide in mediating IL-1-induced NF-kappa B activation and iNOS expression in bovine articular chondrocytes.
    Mendes AF, Caramona MM, Carvalho AP, Lopes MC.
    J Cell Biochem; 2003 Mar 01; 88(4):783-93. PubMed ID: 12577312
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide (NO) and cartilage metabolism: NO effects are modulated by superoxide in response to IL-1.
    Jouzeau JY, Pacquelet S, Boileau C, Nedelec E, Presle N, Netter P, Terlain B.
    Biorheology; 2002 Mar 01; 39(1-2):201-14. PubMed ID: 12082283
    [Abstract] [Full Text] [Related]

  • 10. IL-1 beta induces the degradation of equine articular cartilage by a mechanism that is not mediated by nitric oxide.
    Bird JL, Wells T, Platt D, Bayliss MT.
    Biochem Biophys Res Commun; 1997 Sep 08; 238(1):81-5. PubMed ID: 9299456
    [Abstract] [Full Text] [Related]

  • 11. Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown.
    Cai L, Suboc P, Hogue DA, Fei DT, Filvaroff EH.
    J Rheumatol; 2002 Aug 08; 29(8):1725-36. PubMed ID: 12180737
    [Abstract] [Full Text] [Related]

  • 12. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.
    Armstrong S, Lees P.
    Am J Vet Res; 1999 Jan 08; 60(1):98-104. PubMed ID: 9918155
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2.
    Mastbergen SC, Bijlsma JW, Lafeber FP.
    Ann Rheum Dis; 2008 Jan 08; 67(1):52-8. PubMed ID: 17485421
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide and proteoglycan turnover in rabbit articular cartilage.
    Stefanovic-Racic M, Möllers MO, Miller LA, Evans CH.
    J Orthop Res; 1997 May 08; 15(3):442-9. PubMed ID: 9246092
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of nitric oxide and proteoglycan synthesis due to cyclic tensile strain loaded on chondrocytes attached to fibronectin.
    Matsukawa M, Fukuda K, Yamasaki K, Yoshida K, Munakata H, Hamanishi C.
    Inflamm Res; 2004 Jun 08; 53(6):239-44. PubMed ID: 15167970
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide inhibition of IGF-1 stimulated proteoglycan synthesis: role of cGMP.
    Studer RK, Decker K, Melhem S, Georgescu H.
    J Orthop Res; 2003 Sep 08; 21(5):914-21. PubMed ID: 12919881
    [Abstract] [Full Text] [Related]

  • 17. Effect of phorbol ester on the inhibition of proteoglycan synthesis induced by interleukin 1 and antiinflammatory drugs.
    Hoffman BR, Kandel RA, Cruz TF.
    J Rheumatol; 1993 Oct 08; 20(10):1741-6. PubMed ID: 8295187
    [Abstract] [Full Text] [Related]

  • 18. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures.
    Stefanovic-Racic M, Morales TI, Taskiran D, McIntyre LA, Evans CH.
    J Immunol; 1996 Feb 01; 156(3):1213-20. PubMed ID: 8558000
    [Abstract] [Full Text] [Related]

  • 19. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
    Maneiro E, López-Armada MJ, Fernández-Sueiro JL, Lema B, Galdo F, Blanco FJ.
    J Rheumatol; 2001 Dec 01; 28(12):2692-9. PubMed ID: 11764219
    [Abstract] [Full Text] [Related]

  • 20. Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases.
    Häuselmann HJ, Stefanovic-Racic M, Michel BA, Evans CH.
    J Immunol; 1998 Feb 01; 160(3):1444-8. PubMed ID: 9570565
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.